Cardio Diagnostics +$0 +10.14% Friday 20:00
1D 1W 1M 3M 1Y 5Y
27 Nov Expected
This list is based on the watchlists of people on Stock Events who follow CDIOW. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap 197.08B
Abbott Laboratories offers a broad range of diagnostics products, including cardiovascular diagnostics, competing directly with Cardio Diagnostics' offerings. Quest Diagnostics
DGX
Mkt Cap 17.47B
Quest Diagnostics provides diagnostic testing for conditions including heart diseases, making it a competitor in the cardiovascular diagnostics market. Thermo Fisher Scientific
TMO
Mkt Cap 234.95B
Thermo Fisher Scientific offers products and services for diagnostics, including cardiovascular health, competing in the same space as Cardio Diagnostics. Bio-Rad Laboratories
BIO
Mkt Cap 9.35B
Bio-Rad Laboratories provides clinical diagnostics products, including those for cardiovascular disease, directly competing with Cardio Diagnostics.
Danaher Corporation's diagnostics segment includes products for cardiovascular health, making it a competitor to Cardio Diagnostics.
Laboratory Corporation of America offers a range of diagnostic tests, including for cardiovascular conditions, competing with Cardio Diagnostics. Boston Scientific
BSX
Mkt Cap 120.45B
Boston Scientific Corporation specializes in medical devices for conditions including heart diseases, indirectly competing with Cardio Diagnostics by offering alternative diagnostic solutions. Medtronic
MDT
Mkt Cap 113.61B
Medtronic plc offers medical devices for diagnosing and treating heart conditions, providing an alternative approach to Cardio Diagnostics' solutions.
Hologic, Inc. provides diagnostics products and services, including for cardiovascular health, making it a competitor in the diagnostics market. Agilent Technologies
A
Mkt Cap 41.06B
Agilent Technologies provides laboratories worldwide with instruments, services, consumables, applications, and expertise, including in cardiovascular diagnostics, competing with Cardio Diagnostics.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Show more...
